Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.   

RSS icon
tirzepatide injections Zepbound Eli Lilly

Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards?

Based on positive results from two different trials, Eli Lilly and Company hopes to secure a new FDA approval for tirzepatide in the months ahead.

5:2 intermittent fasting diet

New 5:2 intermittent fasting diet bests metformin, empagliflozin in patients with early-stage type 2 diabetes

The new-look diet was linked to significant weight loss and reductions in HbA1C levels. Researchers see it as a potential alternative to immediately putting patients on new medications. 

Hospira, an Illinois-based pharmaceutical and medical device company owned by Pfizer, has issued a voluntary recall of two different drugs due to ongoing safety issues. The recall includes specific lots of labetalol hydrochloride injections and buprenorphine hydrochloride injections. Labetalol hydrochloride injections are used to control blood pressure in patients with severe hypertension.

Pfizer recalls 2 drugs, including 1 for hypertension, over safety concerns

The recall was put in place due to a leak risk that could make the therapies less effective and potentially lead to an infection. 

Medtronic’s MiniMed 780G automated insulin delivery system

Medtronic automated insulin pump named one of year’s ‘world-changing ideas’

The FDA-approved device includes meal detection technology that can deliver insulin when users lose track of time or underestimate how a meal may affect their health.

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

COVID-19 vaccines helped heart failure patients stay out of the hospital and live longer

Vaccination was linked to key benefits in terms of all-cause mortality, heart failure hospitalizations, stroke, heart attack, myocarditis, venous thromboembolism and testing positive for COVID-19. 

heart patient

New hypertrophic cardiomyopathy guidelines highlight importance of exercise, new drug class

HCM is widely underdiagnosed, but the American College of Cardiology and American Heart Association hope their new guidelines can help cardiologists learn more about the potentially fatal condition and improve patient care. 

Thumbnail

FDA announces Class I recall after insulin pump software causes 224 injuries

The new recall impacts more than 85,000 devices. If users update their iPhone app as recommended, however, they can continue using the insulin pump as directed. 

cannabis use disorder marijuana joint weed smoking

Cardiologists want better data on how legal marijuana will impact heart health in the US

Many states have legalized the recreational use of marijuana in recent years, creating one of the more radical cultural shifts the United States has seen in quite some time. What could this trend mean from a cardiologist's perspective? 

Displaying 57 - 64 of 297
Design by Adaptive Theme